Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 2/2007

01-03-2007 | Case Management and Clinical Consequences

A giant pancreatic serous microcystic adenoma with 20 years follow-up

Authors: Hans-Ulrich Schulz, Udo Kellner, Stefan Kahl, Olaf Effenberger, Walter Asperger, Hans Lippert, Christoph Röcken

Published in: Langenbeck's Archives of Surgery | Issue 2/2007

Login to get access

Abstract

Background and aims

There is only little information about the spontaneous course of large pancreatic serous tumours. We followed up a white woman with a giant serous microcystic adenoma over more than 20 years.

Case report

At first clinical presentation, in 1986, the tumour measured 4.5 cm in diameter. Two years later, it measured 6 cm and was considered as non-resectable at laparotomy. A biopsy was obtained, and the tumour was diagnosed as lymphangioma, based on hematoxylin and eosin-staining. During the follow-up, the tumour progressively increased in size, measuring 12 cm in diameter in 1993 and 17 cm in 2000. Thus, an average growth rate of 0.83 cm per year was calculated. Unspecific abdominal discomfort and pain were the leading clinical symptoms. A colonic resection was necessary because of compression by the tumour in 1993. Portal hypertension was detected at laparotomy. Finally, the initial biopsy specimen was re-evaluated, using immunohistochemistry, and the final diagnosis of a serous microcystic adenoma was made.

Conclusion

This unique case demonstrates that the spontaneous course of serous microcystic adenoma of the pancreas may be favourable even with huge tumour size and that immunohistochemistry may prove a valuable tool for differential diagnosis of cystic pancreatic lesions. Due to their size and progressive, space-occupying growth, these biologically benign tumours may cause injury to adjacent organs and thus clinical symptoms. For this reason, curative surgical resection is the treatment of choice for this tumour entity except for small, asymptomatic lesions, which do not require intervention. When radical resection is impossible, palliative surgery may improve the quality of life for several years. The risk of malignant transformation seems to be low even in the long-term course.
Literature
1.
go back to reference Box JC, Douglas HO (2000) Management of cystic neoplasms of the pancreas. Am Surgeon 66:495–501PubMed Box JC, Douglas HO (2000) Management of cystic neoplasms of the pancreas. Am Surgeon 66:495–501PubMed
2.
go back to reference Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB (2001) Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 81:497–509PubMedCrossRef Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB (2001) Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 81:497–509PubMedCrossRef
3.
go back to reference Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA (2004) Cystic pancreatic neoplasms. Observe or operate. Ann Surg 239:651–659PubMedCrossRef Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA (2004) Cystic pancreatic neoplasms. Observe or operate. Ann Surg 239:651–659PubMedCrossRef
4.
go back to reference Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, Freeny PC (2003) Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions. J Gastrointest Surg 7:417–428PubMedCrossRef Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, Freeny PC (2003) Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions. J Gastrointest Surg 7:417–428PubMedCrossRef
5.
go back to reference Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z (1997) Allelic deletion and mutation of the von Hippel–Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 151:951–956PubMed Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z (1997) Allelic deletion and mutation of the von Hippel–Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 151:951–956PubMed
6.
go back to reference Hamilton SR, Aaltonen LA (eds) (2000) Pathology and genetics of tumours of the digestive system. IARC, Lyon Hamilton SR, Aaltonen LA (eds) (2000) Pathology and genetics of tumours of the digestive system. IARC, Lyon
7.
go back to reference Horvath KD, Chabot JA (1999) An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 178:269–274PubMedCrossRef Horvath KD, Chabot JA (1999) An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 178:269–274PubMedCrossRef
8.
go back to reference Cheng CK, Kanamaru T, Ueno N, Tanaka KI, Idei Y, Nishida Y, Yamamoto M (2001) A case of pancreatic serous cystadenoma obstructing the distal pancreatic duct. Oncol Rep 8:811–813PubMed Cheng CK, Kanamaru T, Ueno N, Tanaka KI, Idei Y, Nishida Y, Yamamoto M (2001) A case of pancreatic serous cystadenoma obstructing the distal pancreatic duct. Oncol Rep 8:811–813PubMed
9.
go back to reference Heim D, Sutter PM, Mattli J, Matter P (1994) Rupturiertes cystadenom des pankreas. Chirurg 65:68–71PubMed Heim D, Sutter PM, Mattli J, Matter P (1994) Rupturiertes cystadenom des pankreas. Chirurg 65:68–71PubMed
10.
go back to reference Marincek B (1995) Serous cystadenoma of the pancreas tail with extensive necrosis and fresh post-traumatic bleeding. Schweiz Rundsch Med Praxis 84:213–215 Marincek B (1995) Serous cystadenoma of the pancreas tail with extensive necrosis and fresh post-traumatic bleeding. Schweiz Rundsch Med Praxis 84:213–215
11.
go back to reference Barbe L, Levy P, Sauvanet A, Flejou JF, Belghiti J, Bernades P (1995) Serous cystadenoma of the pancreas revealed by choledochal stenosis. Gastroenterol Clin Biol 19:848–849PubMed Barbe L, Levy P, Sauvanet A, Flejou JF, Belghiti J, Bernades P (1995) Serous cystadenoma of the pancreas revealed by choledochal stenosis. Gastroenterol Clin Biol 19:848–849PubMed
12.
go back to reference Abe H, Kubota K, Mori M, Miki K, Minagawa M, Noie T, Kimura W, Makuuchi M (1998) Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol 93:1963–1966PubMedCrossRef Abe H, Kubota K, Mori M, Miki K, Minagawa M, Noie T, Kimura W, Makuuchi M (1998) Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol 93:1963–1966PubMedCrossRef
13.
go back to reference Kamei K, Funabiki T, Ochiai M, Amano H, Kasahara M, Sakamoto T (1991) Multifocal pancreatic serous cystadenoma with atypical cells and focal perineural invasion. Int J Pancreatol 10:161–172PubMed Kamei K, Funabiki T, Ochiai M, Amano H, Kasahara M, Sakamoto T (1991) Multifocal pancreatic serous cystadenoma with atypical cells and focal perineural invasion. Int J Pancreatol 10:161–172PubMed
14.
go back to reference El Nakadi B, Greuse M, Debaize JP, Salhadin A (1992) A new complication of cystic neoplasms of the pancreas: cysto-duodenal fistula. Acta Chir Belg 92:52–54PubMed El Nakadi B, Greuse M, Debaize JP, Salhadin A (1992) A new complication of cystic neoplasms of the pancreas: cysto-duodenal fistula. Acta Chir Belg 92:52–54PubMed
15.
go back to reference Haarmann W, Mittelkötter U, Smektala R (1997) Monströses seröses Zystadenomrezidiv des Pankreas. Zentralbl Chir 122:122–125PubMed Haarmann W, Mittelkötter U, Smektala R (1997) Monströses seröses Zystadenomrezidiv des Pankreas. Zentralbl Chir 122:122–125PubMed
16.
go back to reference Ohta T, Nagakawa T, Itoh H, Fonseca L, Miyazaki I, Terada T (1993) A case of serous cystadenoma of the pancreas with focal malignant changes. Int J Pancreatol 14:283–289PubMed Ohta T, Nagakawa T, Itoh H, Fonseca L, Miyazaki I, Terada T (1993) A case of serous cystadenoma of the pancreas with focal malignant changes. Int J Pancreatol 14:283–289PubMed
17.
go back to reference Fujii H, Kubo S, Hirohashi K, Kinoshita H, Yamamoto T, Wakasa K (1998) Serous cystadenoma of the pancreas with atypical cells. Int J Pancreatol 23:165–169PubMed Fujii H, Kubo S, Hirohashi K, Kinoshita H, Yamamoto T, Wakasa K (1998) Serous cystadenoma of the pancreas with atypical cells. Int J Pancreatol 23:165–169PubMed
18.
go back to reference Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C (2005) Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 242:413–421PubMed Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C (2005) Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 242:413–421PubMed
19.
go back to reference Klöppel G, Kosmahl M (2001) Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 1:648–655PubMedCrossRef Klöppel G, Kosmahl M (2001) Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 1:648–655PubMedCrossRef
20.
go back to reference Kamei K, Funabiki T, Ochiai M, Amano H, Marugami Y, Kasahara M, Sakamoto T (1992) Some considerations on the biology of pancreatic serous cystadenoma. Int J Pancreatol 11:97–104PubMed Kamei K, Funabiki T, Ochiai M, Amano H, Marugami Y, Kasahara M, Sakamoto T (1992) Some considerations on the biology of pancreatic serous cystadenoma. Int J Pancreatol 11:97–104PubMed
21.
go back to reference Widmaier U, Mattfeldt T, Siech M, Beger HG (1996) Serous cystadenocarcinoma of the pancreas. Int J Pancreatol 20:135–139PubMed Widmaier U, Mattfeldt T, Siech M, Beger HG (1996) Serous cystadenocarcinoma of the pancreas. Int J Pancreatol 20:135–139PubMed
22.
go back to reference Le Borgne J, de Calan L, Partensky C (1999) Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230:152–161PubMedCrossRef Le Borgne J, de Calan L, Partensky C (1999) Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230:152–161PubMedCrossRef
23.
go back to reference Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32PubMedCrossRef Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32PubMedCrossRef
24.
go back to reference Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, Görich J, Beger HG (1998) Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg 383:56–61PubMedCrossRef Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, Görich J, Beger HG (1998) Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg 383:56–61PubMedCrossRef
25.
go back to reference Kim SG, Wu TT, Lee JH, Yun YK, Issa JP, Hamilton SR, Rashid A (2003) Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Path 16:1086–1094CrossRef Kim SG, Wu TT, Lee JH, Yun YK, Issa JP, Hamilton SR, Rashid A (2003) Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Path 16:1086–1094CrossRef
26.
go back to reference Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M, Scarpa A (2001) Molecular characterization of pancreatic serous microcystic adenomas. Evidence for a tumor suppressor gene on chromosome 10 q. Am J Pathol 158:317–321PubMed Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M, Scarpa A (2001) Molecular characterization of pancreatic serous microcystic adenomas. Evidence for a tumor suppressor gene on chromosome 10 q. Am J Pathol 158:317–321PubMed
27.
go back to reference Moore PS, Beghelli S, Zamboni G, Scarpa A (2003) Genetic abnormalities in pancreatic cancer. Molec Cancer 2:7–12CrossRef Moore PS, Beghelli S, Zamboni G, Scarpa A (2003) Genetic abnormalities in pancreatic cancer. Molec Cancer 2:7–12CrossRef
28.
go back to reference Gerdes B, Wild A, Wittenberg J, Barth P, Ramaswamy A, Kersting M, Lüttges J, Klöppel G, Bartsch DK (2003) Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas 26:42–48PubMedCrossRef Gerdes B, Wild A, Wittenberg J, Barth P, Ramaswamy A, Kersting M, Lüttges J, Klöppel G, Bartsch DK (2003) Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas 26:42–48PubMedCrossRef
29.
go back to reference Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677–1683PubMed Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677–1683PubMed
30.
go back to reference Ishikawa T, Nakao A, Nomoto S, Hosono J, Harada A, Nonami T, Takagi H (1998) Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas 16:40–44PubMedCrossRef Ishikawa T, Nakao A, Nomoto S, Hosono J, Harada A, Nonami T, Takagi H (1998) Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas 16:40–44PubMedCrossRef
Metadata
Title
A giant pancreatic serous microcystic adenoma with 20 years follow-up
Authors
Hans-Ulrich Schulz
Udo Kellner
Stefan Kahl
Olaf Effenberger
Walter Asperger
Hans Lippert
Christoph Röcken
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 2/2007
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-006-0146-1

Other articles of this Issue 2/2007

Langenbeck's Archives of Surgery 2/2007 Go to the issue